Effects of an in vitro vitamin D treatment on the inflammatory responses in visceral adipose tissue from Ldlr−/− mice

키워드

참고문헌 (52)

1. Libby P, "The changing landscape of atherosclerosis", Nature, 592, pp.524~533 (2021)
2. Ross R, "Waist circumference as a vital sign in clinical practice : a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity", Nat Rev Endocrinol, 16, pp.177~189 (2020)
3. Lee BC, "Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance", Biochim Biophys Acta, 1842, pp.446~462 (2014)
4. Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
5. Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance", J Clin Invest, 112, pp.1821~1830 (2003)
6. Fried SK, "Omental and subcutaneous adipose tissues of obese subjects release interleukin-6 : depot difference and regulation by glucocorticoid", J Clin Endocrinol Metab, 83, pp.847~850 (1998)
7. Fain JN, "TNFα release by the nonfat cells of human adipose tissue", Int J Obes, 28, pp.616~622 (2004)
8. Nakamura K, "Adipokines : a link between obesity and cardiovascular disease", J Cardiol, 63, pp.250~259 (2014)
9. Ibrahim MM, "Subcutaneous and visceral adipose tissue : structural and functional differences", Obes Rev, 11, pp.11~18 (2010)
10. Vague J, "The degree of masculine differentiation of obesities : a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease", Am J Clin Nutr, 4, pp.20~34 (1956)
11. Fantuzzi G, "Adipose tissue and atherosclerosis : exploring the connection", Arterioscler Thromb Vasc Biol, 27, pp.996~1003 (2007)
12. Neeland IJ, "Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease : a position statement", Lancet Diabetes Endocrinol, 7, pp.715~725 (2019)
13. Alexopoulos N, "Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis", Atherosclerosis, 233, pp.104~112 (2014)
14. Ohman MK, "Visceral adipose tissue and atherosclerosis", Curr Vasc Pharmacol, 7, pp.169~179 (2009)
15. Gustafson B, "Adipose tissue, inflammation and atherosclerosis", J Atheroscler Thromb, 17, pp.332~341 (2010)
16. Chen GY, "Sterile inflammation : sensing and reacting to damage", Nat Rev Immunol, 10, pp.826~837 (2010)
17. Cole JE, "The expression and functions of toll-like receptors in atherosclerosis", Mediators Inflamm, 2010, pp.393946~ (2010)
18. Sepehri Z, "Toll-like receptor 2 and type 2 diabetes", Cell Mol Biol Lett, 21, pp.2~ (2016)
19. Wang Z, "Toll-like receptor 4 and inflammatory micro-environment of pancreatic islets in type-2 diabetes mellitus : a therapeutic perspective", Diabetes Metab Syndr Obes, 13, pp.4261~4272 (2020)
20. Roshan MH, "The role of TLR2, TLR4, and TLR9 in the pathogenesis of atherosclerosis", Int J Inflamm, 2016, pp.1532832~ (2016)
21. Park CY, "The role of vitamin D in adipose tissue biology : adipocyte differentiation, energy metabolism, and inflammation", J Lipid Atheroscler, 10, pp.130~144 (2021)
22. Ding C, "Vitamin D signalling in adipose tissue", Br J Nutr, 108, pp.1915~1923 (2012)
23. Sadeghi K, "Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns", Eur J Immunol, 36, pp.361~370 (2006)
24. Dickie LJ, "Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes", Rheumatology(Oxford), 49, pp.1466~1471 (2010)
25. Zhang Y, "Vitamin D inhibits monocyte", macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1, 2012, pp.188, 2127~2135
26. Park CY, "Effects of 1, 25-dihydroxyvitamin D3 on the inflammatory responses of stromal vascular cells and adipocytes from lean and obese mice", Nutrients, 12, pp.12~ (2020)
27. Lorente-Cebrián S, "Differential effects of 1α, 25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes", Eur J Nutr, 51, pp.335~342 (2012)
28. Marcotorchino J, "Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes", Mol Nutr Food Res, 56, pp.1771~1782 (2012)
29. Gao D, "1, 25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes", Int J Obes, 37, pp.357~365 (2013)
30. Ding C, "1, 25-Dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes", PLoS One, 8, pp.e61707~ (2013)
31. Karkeni E, "Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice", Endocrinology, 156, pp.1782~1793 (2015)
32. Sun X, "Calcitriol and calcium regulate cytokine production and adipocyte-macrophage crosstalk", J Nutr Biochem, 19, pp.392~399 (2008)
33. Sun X, "Calcium and 1, 25-dihydroxyvitamin D3 regulation of adipokine expression", Obesity(Silver Spring), 15, pp.340~348 (2007)
34. Surdu AM, "Vitamin D and its role in the lipid metabolism and the development of atherosclerosis", Biomedicines, 9, pp.172~ (2021)
35. Riek AE, "1, 25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients", J Steroid Biochem Mol Biol, 136, pp.309~312 (2013)
36. Riek AE, "Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte", macrophage phenotype in type 2 diabetic patients, 2012, pp.287, 38482~38494
37. Tilg H, "Adipocytokines : mediators linking adipose tissue, inflammation and immunity", Nat Rev Immunol, 6, pp.772~783 (2006)
38. Coenen KR, "Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue", Diabetes, 56, pp.564~573 (2007)
39. Bruun JM, "Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue(AT) : implication of macrophages resident in the AT", J Clin Endocrinol Metab, 90, pp.2282~2289 (2005)
40. Chang E, "Effects of vitamin D supplementation on adipose tissue inflammation and NF-κB", AMPK activation in obese mice fed a high-fat diet, 2022, pp.23, 23~
41. Jiménez-Martínez M, "The dual-specificity phosphatase 10(DUSP10) : its role in cancer, inflammation, and immunity", Int J Mol Sci, 20, pp.1626~ (2019)
42. Bijnen M, "Adipose tissue macrophages do not affect atherosclerosis development in mice", Atherosclerosis, 281, pp.31~37 (2019)
43. Luo LJ, "An essential function for MKP5 in the formation of oxidized low density lipid-induced foam cells", Cell Signal, 24, pp.1889~1898 (2012)
44. Zhang X, "Lack of mitogen-activated kinase phosphatase-5 in macrophages protects Ldlr-null mice against atherogenesis", JVS Vasc Sci, 3, pp.423~ (2022)
45. Cohen-Lahav M, "Vitamin D decreases NFκB activity by increasing IκBα levels", Nephrol Dial Transplant, 21, pp.889~897 (2006)
46. Watanabe Y, "Activation and regulation of the pattern recognition receptors in obesityinduced adipose tissue inflammation and insulin resistance", Nutrients, 5, pp.3757~3778 (2013)
47. Uematsu S, "Toll-like receptors and innate immunity", J Mol Med(Berl), 84, pp.712~725 (2006)
48. Ding Y, "Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice", Arterioscler Thromb Vasc Biol, 32, pp.1596~1604 (2012)
49. Owens DM, "Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases", Oncogene, 26, pp.3203~3213 (2007)
50. Pyper SR, "PPARα : energy combustion, hypolipidemia, inflammation and cancer", Nucl Recept Signal, 8, pp.e002~ (2010)
51. Wu JJ, "Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to dietinduced obesity", Cell Metab, 4, pp.61~73 (2006)
52. Khadir A, "MAP kinase phosphatase DUSP1 is overexpressed in obese humans and modulated by physical exercise", Am J Physiol Endocrinol Metab, 308, pp.E71~83 (2015)

관련 논문AI추천